A Comparative Analysis of Lipid Profile Parameters in Type 2 Diabetes Mellitus Patients Undergoing Statin Therapy in Tarhuna
DOI:
https://doi.org/10.65405/.v10i37.655الملخص
Type 2 Diabetes Mellitus (T2DM) is a prevalent metabolic disorder associated with
dyslipidemia, which significantly increases the risk of cardiovascular diseases. Statin therapy is
commonly prescribed to manage lipid profiles in T2DM patients. However, the comparative
efficacy of different statins in this population remains underexplored, particularly in specific
regional contexts such as Tarhuna City, Liby
التنزيلات
المراجع
Adiels, M., Olofsson, S.-O., Taskinen, M.-R., & Boren, J. (2006). Overproduction of
very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic
syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology, 26(6), 1225–1236.
Aga, F., Tesfaye, W., & Gebremariam, G. (2020). Prevalence and associated factors
of diabetes mellitus among patients attending the outpatient department of Bishoftu
General Hospital. BMC Endocrine Disorders, 20(1), 45.
Althanoon, F. H., Abed, H. A., & Abdullah, R. M. (2020). Structural insights into
synthetic statins: Implications for HMG-CoA reductase inhibition. Pharmaceutical
Chemistry Journal, 54(6), 500–507.
Antoniou, S., Christofides, E., & Korantzopoulos, P. (2021). The relationship
between glycemic control and lipid metabolism in patients with T2DM: A clinical
perspective. Journal of Diabetes and Metabolic Disorders, 20(3), 150–159.
Bahar, A., Malik, A., & Ahmad, S. (2023). Statin therapy and lipid profile
modulation: An overview of efficacy and tolerability. Journal of Lipid Research,
64(3), 100117.
Berthézène, P. (2002). Insulin resistance and lipoprotein metabolism. Diabetes &
Metabolism, 28(4 Pt 2), 6S20–6S24.
Chehade, J. M., Gladysz, M., & Mooradian, A. D. (2013). Dyslipidemia in type 2
diabetes: Prevalence, pathophysiology, and management. Drugs, 73(4), 327–339.
Climent, E., García-López, R., & Puig, J. (2021). Statin pharmacodynamics and
pharmacokinetics: Implications for cardiovascular risk management. Current
Atherosclerosis Reports, 23(5), 42–51.
Davies, M. J., D'Alessio, D. A., Fradkin, J., et al. (2018). Management of
hyperglycemia in type 2 diabetes, 2018. A consensus report by the American
Diabetes Association (ADA) and the European Association for the Study of Diabetes
(EASD). Diabetes Care, 41(12), 2669–2701.
Daya, R., Hammad, M., & Elsharif, A. (2017). Prevalence and pattern of
dyslipidemia among type 2 diabetic patients in Libya. Libyan Journal of Medicine,
12(1), 1357440.
Goyal, A. (2023). Type 2 diabetes mellitus: Pathophysiology and clinical features.
International Journal of Endocrinology, 2023, Article ID 5612054.
Hadi, M. A., & AlAteeq, M. A. (2021). The role of statins in managing dyslipidemia
in patients with diabetes mellitus: A review. Journal of Family & Community
Medicine, 28(1), 6–12.
التنزيلات
منشور
إصدار
القسم
الرخصة
هذا العمل مرخص بموجب Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
